Zhenling Liu

1.5k citations
13 papers · 968 indexed · 1 hit paper · h-index 7
Topics
Acute Myeloid Leukemia Research (2 papers)Protein Degradation and Inhibitors (2 papers)Ubiquitin and proteasome pathways (2 papers)
Partner nations
ChinaUnited States

In The Last Decade

Zhenling Liu

13 papers receiving 957 citations

Hit Papers

Angiogenic signaling pathways and anti-angiogenic therapy...20232026202420252023200400600

Peers

Zhenling Liu
Comparison fields: 5 of 105
  • Molecular Biology 473
  • Oncology 201
  • Cancer Research 191
  • Pulmonary and Respiratory Medicine 155
  • Immunology 99
Replace Di Zhang with:
Di Zhang China
Ángeles Carlos‐Reyes Mexico
Wendong Wang China
Zhiming Liu China
Dong Dong China
Jack L. Summers United States
Adam Zalewski United States
Zhenling Liu relative to Di Zhang China Di Zhang's profile →
Citations per field
00.5×1.5×1.8×
Di Zhang · 1×
Citations per year

Countries citing papers authored by Zhenling Liu

Since Specialization
Citations

This map shows the geographic impact of Zhenling Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhenling Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhenling Liu more than expected).

Fields of papers citing papers by Zhenling Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhenling Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhenling Liu. The network helps show where Zhenling Liu may publish in the future.

Co-authorship network of co-authors of Zhenling Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Zhenling Liu. A scholar is included among the top collaborators of Zhenling Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhenling Liu. Zhenling Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
#WorkIndexed citations
1 3
2 4
3 2
4
Angiogenic signaling pathways and anti-angiogenic therapy for cancerbreakdown →
647
5 3
6 11
7 1
8 27
9 91
10
[Phenolic components from Rhodiola dumulosa].
4
11 17
12 92
13 66

About Zhenling Liu

Zhenling Liu is a scholar working on Hematology, Pharmacology and Physiology, having authored 13 papers that have together received 968 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (2 papers), Protein Degradation and Inhibitors (2 papers) and Ubiquitin and proteasome pathways (2 papers). The work is most often cited by research in Endocrinology (65 citations), Cancer Research (191 citations) and Molecular Medicine (60 citations). Zhenling Liu has collaborated with scholars based in China and United States. Frequent co-authors include Lili Zheng, Lei Shi, Huanhuan Chen, Li‐Ping Sun, Susan Whittier, Lisa Saiman, Setareh Tabibi, Juyan Zhou, Pablo Gabriel and Yunhua Chen. Their work appears in journals such as Nature Communications, Journal of Clinical Microbiology and Genome biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026